SCHEMBL7457646

SCHEMBL7457646

CNC(=O)c1cccc(F)c1C(N)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.62
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
PLK1 P53350 1/20 0.46
ALDH1A1 P00352 1/20 0.44
JAK2 O60674 3/20 0.41
JAK1 P23458 2/20 0.41
TYK2 P29597 2/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ITGB2 P05107 1/20 0.41
ICAM1 P05362 1/20 0.41
ITGAL P20701 1/20 0.41
LMNA P02545 1/20 0.40
BCHE P06276 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HTT P42858 1/20 0.39
NOD2 Q9HC29 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7456302 0.86 GAA (0.58) GAACES2CES1PLK1ALDH1A1
SCHEMBL11266406 0.81 CES2 (0.54) GAACES2CES1ALDH1A1KMT2A
SCHEMBL29349853 0.81 CES2 (0.54) GAACES2CES1ALDH1A1KMT2A
SCHEMBL4621991 0.81 PLK1 (0.47) GAAPLK1ALDH1A1
Ammonia Solution, Strong SCHEMBL11279325 0.80 ALB (0.55) GAACES2CES1ALDH1A1KMT2A
Ammonia Solution, Strong SCHEMBL10950194 0.80 ALB (0.55) GAACES2CES1ALDH1A1KMT2A
Bromide SCHEMBL29924937 0.80 CES2 (0.52) GAACES2CES1ALDH1A1KMT2A
SCHEMBL7453379 0.79 GAA (0.49) GAACES2CES1PLK1ALDH1A1
SCHEMBL13735592 0.79 ALDH1A1 (0.49) CES2CES1ALDH1A1KMT2ALMNA
SCHEMBL27497363 0.79 DOT1L (0.47) GAAPLK1ALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP claimed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A GAA 963/4885CES2 241/4885CES1 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.